Clinical outcomes and etiology of acquired sixth cranial nerve palsy.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
18 Mar 2022
18 Mar 2022
Historique:
received:
08
09
2021
received:
24
02
2022
accepted:
26
02
2022
entrez:
31
3
2022
pubmed:
1
4
2022
medline:
7
4
2022
Statut:
ppublish
Résumé
The objective of this study was to investigate the difference in clinical features according to age and factors affecting recovery of acquired sixth cranial nerve (CN6) palsy.A total of 156 patients with acute CN6 palsy between March 2016 and August 2021 who were followed up for at least 3 months were included in this study. Etiology, rate of recovery, and factors associated with recovery were retrospectively investigated.The average age of patients with CN6 palsy was about 60years and the mean duration of recovery was about 2.5 months. Of 156 patients, 72 (46.15%) had a microvascular etiology and 25 (16.03%) patients had a brain vascular lesions. Brain neoplasm, trauma, and "others" were found in 10 (6.41%), 11 (7.05%), and 15 (9.62%) patients, respectively. Among the total of 156 patients, 28 (17.95%) failed to completely recover. Non-isolated CN6 palsy with other cranial nerve palsies were recorded in 29 (18.59%) cases. Comparison of age (<50years vs ≥50years), between recovery and non-recovery groups showed that etiology was significantly different.The recovery rate of acquired CN6 palsy was about 82% and about 27% of patients had brain lesions. Also, varying rates and duration of recovery were found according to etiology, so we should be pay attention to diagnosis of causative disease in CN6 palsy patients.
Identifiants
pubmed: 35356946
doi: 10.1097/MD.0000000000029102
pii: 00005792-202203180-00049
pmc: PMC10684240
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Références
J Clin Neurol. 2019 Apr;15(2):221-227
pubmed: 30938109
Eye (Lond). 1996;10 ( Pt 3):377-84
pubmed: 8796166
Ophthalmology. 2005 May;112(5):760-3
pubmed: 15878054
Arch Ophthalmol. 1960 Jan;63:84-91
pubmed: 14446219
Am J Ophthalmol. 2002 Jul;134(1):81-4
pubmed: 12095812
Ophthalmology. 2013 Nov;120(11):2264-9
pubmed: 23747163
Jpn J Ophthalmol. 2008 Jan-Feb;52(1):32-5
pubmed: 18369697
Eye (Lond). 2019 Jun;33(6):965-973
pubmed: 30760897
Arch Ophthalmol. 1981 Jan;99(1):76-9
pubmed: 7458744
Korean J Ophthalmol. 2018 Jun;32(3):221-227
pubmed: 29770635
Arch Ophthalmol. 2011 Mar;129(3):301-5
pubmed: 21402985
Ophthalmology. 2004 Feb;111(2):369-75
pubmed: 15019392
Am J Ophthalmol. 1992 May 15;113(5):489-96
pubmed: 1575221
Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb;9(1):25-28
pubmed: 31990742
J Neurol Sci. 2019 Dec 15;407:116546
pubmed: 31669731
J Neuroophthalmol. 2015 Mar;35(1):37-40
pubmed: 25594670
Curr Neurol Neurosci Rep. 2016 Aug;16(8):69
pubmed: 27306521
Eye (Lond). 2008 May;22(5):691-6
pubmed: 17293794
Ophthalmology. 2002 Oct;109(10):1925-8
pubmed: 12359616
Sci Rep. 2019 Dec 5;9(1):18419
pubmed: 31804597